Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel M Rubinstein

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
The Oncologist|May 5, 2022
Physical Function, Psychosocial Status, and Symptom Burden Among Adults with Plasma Cell Disorders and Associations with Quality of LifeChristopher E Jensen, Sanah N Vohra, Kirsten A Nyrop, et al.
Journal of Geriatric Oncology|April 28, 2022
Prevalence and clinical correlates of cognitive impairment in adults with plasma cell disordersZev M Nakamura, Sanah N Vohra, Christopher E Jensen, et al.
The Oncologist|March 13, 2020
The Impact of Nonsteroidal Anti-Inflammatory Drugs, Beta Blockers, and Metformin on the Efficacy of Anti-PD-1 Therapy in Advanced MelanomaDaniel Y Wang, Jennifer L McQuade, Rajat R Rai, et al.
Cancer Medicine|January 27, 2026
Treatment Initiation Among Black and White Older Adults With Multiple Myeloma: A SEER-Medicare AnalysisMatthew R LeBlanc, Xi Zhou, Christopher D Baggett, et al.
Clinical Pharmacology and Therapeutics|February 2, 2026
Causal Effects of Hydrophilic Bile Acids on Carfilzomib-Related Cardiovascular Events in Multiple Myeloma: A Mendelian Randomization StudySamia Shabnaz, Eric Farber-Eger, Marwa Tantawy, et al.
Leukemia & Lymphoma|June 12, 2019
Clinicopathologic correlates of <i>MYD88</i> L265P mutation and programmed cell death (PD-1) pathway in primary central nervous system lymphomaTarsheen K Sethi, Alexandra E Kovach, Natalie S Grover, et al.
Blood Advances|February 24, 2026
Feasibility of Decentralized Real-World Monitoring of SARS-CoV-2 Booster Vaccines and COVID-19 Outcomes in MyelomaWilliam A Wood, Shaji K Kumar, Emily Semmel, et al.
JAMA Oncology|June 17, 2021
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19Michael A Thompson, Jeffrey P Henderson, Pankil K Shah, et al.
Scientific Reports|October 17, 2020
Seven decades of chemotherapy clinical trials: a pan-cancer social network analysisXuanyi Li, Elizabeth A Sigworth, Adrianne H Wu, et al.
The Lancet. Oncology|February 17, 2018
Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysisJennifer L McQuade, Carrie R Daniel, Kenneth R Hess, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
The Oncologist|May 5, 2022
Physical Function, Psychosocial Status, and Symptom Burden Among Adults with Plasma Cell Disorders and Associations with Quality of LifeChristopher E Jensen, Sanah N Vohra, Kirsten A Nyrop, et al.
Journal of Geriatric Oncology|April 28, 2022
Prevalence and clinical correlates of cognitive impairment in adults with plasma cell disordersZev M Nakamura, Sanah N Vohra, Christopher E Jensen, et al.
The Oncologist|March 13, 2020
The Impact of Nonsteroidal Anti-Inflammatory Drugs, Beta Blockers, and Metformin on the Efficacy of Anti-PD-1 Therapy in Advanced MelanomaDaniel Y Wang, Jennifer L McQuade, Rajat R Rai, et al.
Cancer Medicine|January 27, 2026
Treatment Initiation Among Black and White Older Adults With Multiple Myeloma: A SEER-Medicare AnalysisMatthew R LeBlanc, Xi Zhou, Christopher D Baggett, et al.
Clinical Pharmacology and Therapeutics|February 2, 2026
Causal Effects of Hydrophilic Bile Acids on Carfilzomib-Related Cardiovascular Events in Multiple Myeloma: A Mendelian Randomization StudySamia Shabnaz, Eric Farber-Eger, Marwa Tantawy, et al.
Leukemia & Lymphoma|June 12, 2019
Clinicopathologic correlates of <i>MYD88</i> L265P mutation and programmed cell death (PD-1) pathway in primary central nervous system lymphomaTarsheen K Sethi, Alexandra E Kovach, Natalie S Grover, et al.
Blood Advances|February 24, 2026
Feasibility of Decentralized Real-World Monitoring of SARS-CoV-2 Booster Vaccines and COVID-19 Outcomes in MyelomaWilliam A Wood, Shaji K Kumar, Emily Semmel, et al.
JAMA Oncology|June 17, 2021
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19Michael A Thompson, Jeffrey P Henderson, Pankil K Shah, et al.
Scientific Reports|October 17, 2020
Seven decades of chemotherapy clinical trials: a pan-cancer social network analysisXuanyi Li, Elizabeth A Sigworth, Adrianne H Wu, et al.
The Lancet. Oncology|February 17, 2018
Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysisJennifer L McQuade, Carrie R Daniel, Kenneth R Hess, et al.
Pageof 6